Background Herpes zoster (HZ) is caused by reactivation of the varicella-zoster virus (VZV)
and mainly affects individuals aged≥ 50 years. The forthcoming European launch of a …

Neuropathic orofacial pain is a general term employed to describe a number of clinical
syndromes, which may be spontaneous or triggered by local trauma or systemic disorders …

Background The potentially serious nature of herpes zoster (HZ) and the long-term
complication post-herpetic neuralgia (PHN) are often underestimated. One in four people …

Background Data on the epidemiology and cost of herpes zoster (HZ) and post-herpetic
neuralgia (PHN) in Italy are limited. This retrospective, population-based study was …

Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the
quality of life of affected patients. Different therapeutic approaches to treat acute HZ are …

Background Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus
(VZV) and mainly affects individuals aged≥ 50 years. Vaccines have been licensed or are …

A live-attenuated vaccine against herpes zoster (HZ) has been approved for use, on the
basis of a large-scale clinical trial that suggests that the vaccine is safe and efficacious. This …

Objective: Neuropathic pain is often difficult to treat due to a complex pathophysiology. This
study evaluated the efficacy, tolerability and safety of combination therapy with 5% lidocaine …

Herpes zoster (HZ; shingles)–a reactivation of the latent varicella zoster virus (VZV)–can
cause significant morbidity. Its major complication is pain, particularly post-herpetic …

Background Herpes zoster (HZ) or “shingles” is common in persons aged 50 years or over.
HZ is characterised by a painful dermatological rash which typically resolves in …